论文信息 - Rifampicin-macrolide synergy against Legionella pneumophila serogroup 1 in human macrophages using a quantitative real-time PCR assay. - 字舞流文

Rifampicin-macrolide synergy against Legionella pneumophila serogroup 1 in human macrophages using a quantitative real-time PCR assay.

G. Lina | F. Forey | J. Etienne | S. Jarraud | F. Ader | C. Ginevra | G. Descours

[1] J. Garau,et al. Impact of rifampicin addition to clarithromycin in Legionella pneumophila pneumonia. , 2006, International journal of antimicrobial agents.

[2] M. Maurin,et al. Antibiotic susceptibilities of Legionella pneumophila strain Paris in THP-1 cells as determined by real-time PCR assay. , 2005, The Journal of antimicrobial chemotherapy.

[3] M. Franke,et al. Antibacterial Effects of Levofloxacin, Erythromycin, and Rifampin in a Human Monocyte System againstLegionella pneumophila , 1998, Antimicrobial Agents and Chemotherapy.

[4] L. Saravolatz,et al. Effect of quinolones and other antimicrobial agents on cell-associated Legionella pneumophila , 1987, Antimicrobial Agents and Chemotherapy.

[5] P. Rajagopalan,et al. Inhibition of Legionella pneumophila multiplication within human macrophages by antimicrobial agents , 1986, Antimicrobial Agents and Chemotherapy.